Skip to Main Content

Author Details

Dean A Troyer
Eastern Virginia Medical School
1985
148
52
PMIDPaper TitleJournal TitlePublished Year
36097168Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy.Prostate Cancer Prostatic Dis2024
37343766Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study.Mod Pathol2023
37550801ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.J Pathol2023
37189628Differential Activation of NRF2 Signaling Pathway in Renal-Cell Carcinoma Caki Cell Lines.Biomedicines2023
35145197Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25â¿¿mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinoma.Mod Pathol2022
36061737Site-Specific Intact N-Linked Glycopeptide Characterization of Prostate-Specific Membrane Antigen from Metastatic Prostate Cancer Cells.ACS Omega2022
35176252Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosis.Hum Pathol2022
34339576Assessment of the Banff Working Group classification of definitive BK polyomavirus nephropathy.Transpl Int2021
33674181Blood Test for Cancer: Are We There Yet?Eur Urol2021
33617334Restriction Spectrum Imaging-Magnetic Resonance Imaging to Improve Prostate Cancer Imaging in Men on Active Surveillance.J Urol2021
33019829Collapsing Focal Segmental Glomerulosclerosis and Acute Oxalate Nephropathy in a Patient With COVID-19: A Double Whammy.J Investig Med High Impact Case Rep2020
32071439Copy number alterations are associated with metastatic-lethal progression in prostate cancer.Prostate Cancer Prostatic Dis2020
32665124A copy number gain on 18q present in primary prostate tumors is associated with metastatic outcome.Urol Oncol2020
32605857High-risk Prostate Cancer Patients Are Not All Alike.Eur Urol2020
26902887DNA methylation profiles in African American prostate cancer patients in relation to disease progression.Genomics2019
29464091Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer.Oncotarget2018
29937939Technical Feasibility of Tissue Microarray (TMA) Analysis of Tumor-Associated Immune Response in Prostate Cancer.J Cancer2018
29956356A five-CpG DNA methylation score to predict metastatic-lethal outcomes in men treated with radical prostatectomy for localized prostate cancer.Prostate2018
27358489Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer.Clin Cancer Res2017
28145099Gene expression panel predicts metastatic-lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancer.Mol Oncol2017
26924343Roles of Distal and Genic Methylation in the Development of Prostate Tumorigenesis Revealed by Genome-wide DNA Methylation Analysis.Sci Rep2016
26327354Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort.J Urol2016
26530043Complex-I Alteration and Enhanced Mitochondrial Fusion Are Associated With Prostate Cancer Progression.J Cell Physiol2016
27617307PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer.Eur Urol Focus2016
27846218MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study.PLoS One2016
27635949Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort.Am J Surg Pathol2016
27174589Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH.Mod Pathol2016
27325561Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy Cohort.Prostate2016
27350604Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer.Nat Commun2016
27136741Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies.Prostate Cancer Prostatic Dis2016
27578275Metabolite Analysis and Histology on the Exact Same Tissue: Comprehensive Metabolomic Profiling and Metabolic Classification of Prostate Cancer.Sci Rep2016
27011882Robotic-assisted laparoscopic partial cystectomy for symptomatic urachal hamartoma.Turk J Urol2016
25939393A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer.Prostate2015
26497208Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer.Oncotarget2015
26172920Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients.PLoS One2015
24200968miR-888 is an expressed prostatic secretions-derived microRNA that promotes prostate cell growth and migration.Cell Cycle2014
25593999MDA-9/Syntenin regulates differentiation and angiogenesis programs in head and neck squamous cell carcinoma.Oncoscience2014
25184632MALDI imaging mass spectrometry profiling of N-glycans in formalin-fixed paraffin embedded clinical tissue blocks and tissue microarrays.PLoS One2014
24747657Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies.J Urol2014
24497498MALDI imaging mass spectrometry profiling of proteins and lipids in clear cell renal cell carcinoma.Proteomics2014
23232570A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray.Adv Anat Pathol2013
23775902Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression.Proteomics Clin Appl2013
23732709Acid ceramidase induces sphingosine kinase 1/S1P receptor 2-mediated activation of oncogenic Akt signaling.Oncogenesis2013
23485507Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing.J Urol2013
23533145In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.Proteomics2013
22339264Identification of prostate-enriched proteins by in-depth proteomic analyses of expressed prostatic secretions in urine.J Proteome Res2012
22986220Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer.Mol Cell Proteomics2012
22546470Cancer detection and biopsy classification using concurrent histopathological and metabolomic analysis of core biopsies.Genome Med2012
21321980Blockade of transforming growth factor-beta (TGFβ) signaling inhibits osteoblastic tumorigenesis by a novel human prostate cancer cell line.Prostate2011
22188997Molecular preservation by extraction and fixation, mPREF: a method for small molecule biomarker analysis and histology on exactly the same tissue.BMC Clin Pathol2011
  • 1 - 50 of 148

Recommended Authors

Patrizia Moser
Medical University of Innsbruck
Career Start Year 1999
Number of shared co-authors 0
Dolores Di Vizio
Cedars-Sinai Medical Center
Career Start Year 1997
Number of shared co-authors 5
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 13
Michael R Emmert-Buck
The Francis Crick Institute
Career Start Year 1994
Number of shared co-authors 7
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Borko Jovanovic
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year 1991
Number of shared co-authors 1
Suzanne Carreira
The Institute of Cancer Research
Career Start Year 1990
Number of shared co-authors 8
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 4
Madeleine Moussa
Schulich School of Medicine and Dentistry, University of Western Ontario
Career Start Year 1989
Number of shared co-authors 5
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Career Start Year 1988
Number of shared co-authors 5
Michael R Freeman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 1987
Number of shared co-authors 6
Gregory A Michelotti
Inc. Research Triangle Park
Career Start Year 1987
Number of shared co-authors 0
Beatrice S Knudsen
University of Utah
Career Start Year 1986
Number of shared co-authors 21
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Stephen R Pennington
UCD Conway Institute, University College Dublin
Career Start Year 1985
Number of shared co-authors 2
Massimo Loda
Weill Medical College of Cornell University
Career Start Year 1984
Number of shared co-authors 20
David M Nanus
Sandra and Edward Meyer Cancer Center
Career Start Year 1983
Number of shared co-authors 8
Michael J Becich
University of Pittsburgh School of Medicine
Career Start Year 1982
Number of shared co-authors 2
David M Berman
Queen's University
Career Start Year 1982
Number of shared co-authors 20
Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 1981
Number of shared co-authors 20
Steven P Balk
Beth Israel Deaconess Medical Center and Harvard Medical School
Career Start Year 1981
Number of shared co-authors 13
Eleftherios P Diamandis
Lunenfeld-Tanenbaum Research Institute
Career Start Year 1981
Number of shared co-authors 11
Eric J Bergstralh
Mayo Clinic
Career Start Year 1980
Number of shared co-authors 1
William B Isaacs
The Brady Urological Institute, The Johns Hopkins School of Medicine
Career Start Year 1979
Number of shared co-authors 23
David J Orlicky
University of Colorado School of Medicine
Career Start Year 1978
Number of shared co-authors 2
Christopher S Foster
The Institute of Cancer Research
Career Start Year 1978
Number of shared co-authors 2
Ralph Buttyan
University of British Columbia
Career Start Year 1976
Number of shared co-authors 8
Robert L Vessella
University of Washington
Career Start Year 1974
Number of shared co-authors 19
Karin D Rodland
Oregon Health and Science University
Career Start Year 1973
Number of shared co-authors 9
Christer Busch
Uppsala University
Career Start Year 1970
Number of shared co-authors 0

Collaborators

Ian M Thompson
CHRISTUS Santa Rosa Hospital-Medical Center
Co-authored papers 45
Raymond S Lance
Washington State University Elson S. Floyd College of Medicine
Co-authored papers 26
Robin J Leach
University of Texas Health San Antonio
Co-authored papers 20
Oliver J Semmes
Eastern Virginia Medical School
Co-authored papers 18
Daniel W Lin
Co-authored papers 17
Ladan Fazli
University of British Columbia
Co-authored papers 15
Peter S Nelson
Fred Hutchinson Cancer Center
Co-authored papers 15
Richard R Drake
Medical University of South Carolina
Co-authored papers 15
Lawrence D True
University of Washington School of Medicine
Co-authored papers 15
Martin E Gleave
University of British Columbia
Co-authored papers 14
Antonio Hurtado-Coll
University of British Columbia
Co-authored papers 13
Bysani Chandrasekar
Co-authored papers 9
Julius O Nyalwidhe
Eastern Virginia Medical School
Co-authored papers 9
Brad H Pollock
University of California davis
Co-authored papers 6
Janet L Stanford
Fred Hutchinson Cancer Research Center
Co-authored papers 5
Elaine A Ostrander
National Cancer Institute
Co-authored papers 5
Jonathan L Wright
University of Washington Medical Center
Co-authored papers 5
Teresa L Johnson-Pais
University of Texas Health San Antonio
Co-authored papers 5
Suzanne Kolb
Fred Hutchinson Cancer Research Center
Co-authored papers 5
Jian-Bing Fan
Nanfang Hospital and Basic Medical College, Southern Medical University
Co-authored papers 4
Yunee Kim
University of Toronto
Co-authored papers 4
Thomas Kislinger
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 4
Sudhir Srivastava
National Cancer Institute
Co-authored papers 4
Vladimir Ignatchenko
Margaret Cancer Center
Co-authored papers 3
Marina Bibikova
Departments of Bioinformatics and Clinical Genomics, Illumina Inc.
Co-authored papers 3
Tamara Jamaspishvili
Queen's University
Co-authored papers 3
Jeremy A Squire
University of Sao Paulo
Co-authored papers 3
Alan W Partin
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 3
Zhen Zhang
Co-authored papers 3
William E Grizzle
University of Alabama at Birmingham
Co-authored papers 3
Release 1.2